NuProbeNucleic acid diagnostics
NuProbe utilizes DNA toehold probe systems to develop non-invasive cancer and infectious disease diagnostics
Root RoboticsRobots teaching kids to code
Root Robotics is commercializing Root, an educational and interactive robot to teach coding to many age groups and experience levels.
Wyss Technology: Root
Website: Root Robotics
News: CES 2018: The Root aims to teach kindergartners how to code
News: TechRadar's 2018 CES Awards – the best tech at the show
News: Harvard’s Wyss Institute launches Root Robotics, an educational startup to get anyone coding
ReadCoor leverages the Wyss Institute’s method for simultaneously sequencing and mapping thousands of RNAs within cells and tissues to advance development of diagnostics and discover new drug targets
FreeFlow Medical DevicesNon-stick coatings for medical devices
FreeFlow Medical Devices
FreeFlow Medical Devices uses an anti-adhesive coating technology to eliminate the formation of biofilms and blood clots on the surfaces of medical devices
Wyss Technology: Tethered Liquid Perfluorocarbon (TLP), a non-stick coating for medical devices
Website: FreeFlow Medical Devices
News: Bioinspired coating for medical devices repels blood and bacteria
Video: Bioinspired Blood Repellent Coating
Adaptive Surface TechnologiesSlippery surfaces
Adaptive Surface Technologies
Adaptive Surface Technologies (formerly SLIPS Technologies, Inc.) leverages the Wyss Institute’s Slippery Liquid-Infused Porous Surfaces (SLIPS) technology to create a family of materials and coatings that repel virtually all fluids and biological fouling agents in industrial, medical, and consumer applications
Wyss Technology: SLIPS (Slippery Liquid-Infused Porous Surfaces)
Website: Adaptive Surface Technologies
News: Johnson & Johnson Innovation Announces New Collaborations Advancing Ground-Breaking Biomedical Innovation Around the Globe
News: SLIPS Technologies Announces $8.6 Million in New Funding Round
News: Materials and engineering: Rebuilding the world
News: Wyss Institute launches ‘SLIPS’ company
Emulate leverages the Wyss Institute’s organs-on-chips technology to emulate human biology towards understanding how diseases, medicines, chemicals, and foods affect human health
Wyss Technology: Human Organs-on-Chips
News: Founders Fund Leads $36 Million Financing Round in Emulate, Inc.
News: Emulate, Inc. and AstraZeneca form strategic agreement to work side-by-side on Organs-on-Chips technology to improve prediction of human safety and efficacy of drug candidates
News: Emulate, Inc. Awarded Grant to Fund Use of Human Emulation System aboard the International Space Station
News: ‘Organs-on-Chips’ Technology: FDA Testing Groundbreaking Science
News: Organ-On-A-Chip Startup, Emulate, Grabs $45M to Shake Up Drug Discovery
News: Wyss Institute’s technology translation engine launches ‘Organs-on-Chips’ company
Ultivue is developing innovative imaging solutions to unfold new areas of biology by leveraging the Institute’s DNA-PAINT technology. At the center of the technology is the transient binding of fluorophores to targets mediated by DNA-DNA interaction
Wyss Technology: Inexpensive Super-Resolution Microscopy
News: Ultivue Launches UltiMapper™ Portfolio of Reagents for Tissue Marker Detection and Analysis at High Level of Multiplexing and Throughput
News: Ultivue Inc. Announces Completion of its Series B Financing
News: Harvard’s Wyss Institute launches Ultivue to facilitate super-resolution microscopy
MediCollectorBedside data acquisition
MediCollector uses the Institute’s data acquisition algorithms to enable continuous collection of data to better characterize physiological changes and treatment in patients
BIOMODBiomolecular design competition
Birthed at the Wyss Institute, BIOMOD is now an independent, international biomolecular design competition based in San Fransisco
CRISPR-mediated organ engineeringeGenesis
CRISPR-mediated organ engineering
eGenesis is facilitating the development of safe and effective cells, tissues, and organs for future medical transplantation into human patients.
Biomaterial-based cancer immunotherapyNovartis
Biomaterial-based cancer immunotherapy
Novartis is developing a therapeutic, biomaterial-based, cancer vaccine that promotes anti-cancer immunity for specific targets.
Wyss Technology: Implantable cancer vaccine
News: Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
News: First cancer vaccine to eliminate tumors in mice
News: Cross-disciplinary team from Harvard University and Dana-Farber Cancer Institute brings novel therapeutic cancer vaccine to human clinical trials
News: Injectable 3D vaccines could fight cancer and infectious diseases
News: Personal cancer vaccine gets their own boost
News: Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis
Minimally invasive surgical deviceHoliStick Medical
Minimally invasive surgical device
A specialized catheter device that can repair holes in the heart or tissue defects in other organs has been licensed by HoliStick Medical. Designed to work with sticky and flexible materials such as patches, the device incorporates mechanisms to delicately close a hole without requiring the use of sutures or rigid devices.
Soft exosuit for strokeRewalk Robotics
Soft exosuit for stroke
The Institute’s soft exosuit technology has been licensed by ReWalk Robotics, Ltd. towards further development of concepts and designs of lightweight exoskeleton system technologies for medical applications such as stroke and multiple sclerosis. Licensing opportunities are available for other soft exosuit applications.
Wyss Technology: Soft exosuit
News: Post-stroke patients reach terra firma with Wyss Institute’s exosuit technology
News: Wyss Institute collaborates with Rewalk Robotics to develop wearable exosuit for patients with limited mobility
3D printed electronic partsVoxel8
3D printed electronic parts
Voxel8 integrates capabilities in materials science, software, and hardware to produce an additive manufacturing platform that co-prints hard, soft, and electronic materials for functional industrial parts. The company is leveraging some of the Institute’s 3D printed electronic parts.
CRISPR genome editingEditas Medicine
CRISPR genome editing
Editas is leveraging Institute CRISPR technology towards genome editing for the treatment of patients with genetically defined diseases.
Artificial robot swarms for education and researchK-Team Corporation
Artificial robot swarms for education and research
A collective of 1024 ‘Kilobots’ (a kilo of robots) that can be programmed to exhibit complex swarming behaviors has been licensed by K-Team Corporation, which is manufacturing and marketing the novel robot "swarm" system for use in education and research.
Ultraspecific nucleic acid hybridization probes for detection and countingNanoString Technologies
Ultraspecific nucleic acid hybridization probes for detection and counting
A new class of ultraspecific nucleic acid hybridization probes that can improve the detection of naturally occurring genetic sequences has been licensed to NanoString Technologies. Licensing opportunities are available for other applications.